(Q33370654)

English

Postoperative interferon alpha treatment postponed recurrence and improved overall survival in patients after curative resection of HBV-related hepatocellular carcinoma: a randomized clinical trial

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Postoperative interferon alpha treatment postponed recurrence and improved overall survival in patients after curative resection of HBV-related hepatocellular carcinoma: a randomized clinical trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

author name string

Hui-Chuan Sun

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Zhao-You Tang

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Lu Wang

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Lun-Xiu Qin

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Zeng-Chen Ma

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Qin-Hai Ye

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Bo-Heng Zhang

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Yong-Bin Qian

8

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Zhi-Quan Wu

9

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Jia Fan

10

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Xin-Da Zhou

11

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Jian Zhou

12

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Shuang-Jian Qiu

13

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Yue-Fang Shen

14

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

publication date

24 March 2006

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Journal of Cancer Research and Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

132

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

458-465

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Effects of long-term postoperative interferon-alpha therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS00432-006-0091-Y

21 January 2018

Quantitative HBV DNA levels as an early predictor of nonresponse in chronic HBe-antigen positive hepatitis B patients treated with interferon-alpha

1 reference

https://pubmed.ncbi.nlm.nih.gov/16557381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term follow-up of Japanese patients with chronic hepatitis B treated with interferon-alpha.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16557381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Progress and prospects in hepatocellular carcinoma surgery

1 reference

https://pubmed.ncbi.nlm.nih.gov/16557381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Appraisal of postoperative transcatheter arterial chemoembolization (TACE) for prevention and treatment of hepatocellular carcinoma recurrence]

1 reference

https://pubmed.ncbi.nlm.nih.gov/16557381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/16557381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Postoperative adjuvant hepatic arterial infusion of Lipiodol containing anticancer drugs in patients with hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/16557381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Postoperative adjuvant chemotherapy after curative resection of hepatocellular carcinoma: a randomized controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/16557381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective randomized controlled study of interferon-alpha in preventing hepatocellular carcinoma recurrence after medical ablation therapy for primary tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/16557381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of hepatitis B virus-related hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/16557381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16557381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/16557381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant chemotherapy with epirubicin and carmofur after radical resection of hepatocellular carcinoma: a prospective randomized study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16557381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanism of interferon alpha on inhibition of metastasis and angiogenesis of hepatocellular carcinoma after curative resection in nude mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/16557381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon alfa receptor expression and growth inhibition by interferon alfa in human liver cancer cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/16557381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatitis B virus-related hepatocellular carcinogenesis and its prevention

1 reference

https://pubmed.ncbi.nlm.nih.gov/16557381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of second primary tumors by an acyclic retinoid in patients with hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/16557381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survival and recurrence after hepatic resection of 386 consecutive patients with hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/16557381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term follow-up of interferon alfa treatment in Chinese patients with chronic hepatitis B infection: The effect on hepatitis B e antigen seroconversion and the development of cirrhosis-related complications

1 reference

https://pubmed.ncbi.nlm.nih.gov/16557381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk factors for early death due to recurrence after liver resection for hepatocellular carcinoma: results of a multicenter study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16557381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor-A prospective randomized study of hepatitis C virus-related liver cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16557381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/16557381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16557381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years

1 reference

https://pubmed.ncbi.nlm.nih.gov/16557381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Postoperative adjuvant chemotherapy after radical hepatic resection for hepatocellular carcinoma (HCC)

1 reference

https://pubmed.ncbi.nlm.nih.gov/16557381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meta-analysis: evaluation of adjuvant therapy after curative liver resection for hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/16557381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose and long-term therapy with interferon-alfa inhibits tumor growth and recurrence in nude mice bearing human hepatocellular carcinoma xenografts with high metastatic potential

1 reference

https://pubmed.ncbi.nlm.nih.gov/16557381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon-alpha sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-kappa B inactivation

1 reference

https://pubmed.ncbi.nlm.nih.gov/16557381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon-alpha 2a up-regulated thymidine phosphorylase and enhanced antitumor effect of capecitabine on hepatocellular carcinoma in nude mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/16557381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Factors predicting response and survival in 149 patients with unresectable hepatocellular carcinoma treated by combination cisplatin, interferon-alpha, doxorubicin and 5-fluorouracil chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/16557381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined therapy consisting of intraarterial cisplatin infusion and systemic interferon-alpha for hepatocellular carcinoma patients with major portal vein thrombosis or distant metastasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16557381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Power and sample size calculations. A review and computer program

1 reference

https://pubmed.ncbi.nlm.nih.gov/16557381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/16557381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary prevention of hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/16557381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized clinical trial of long-term outcome after resection of hepatitis C virus-related hepatocellular carcinoma by postoperative interferon therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/16557381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of systemic continuous fluorouracil and subcutaneous recombinant interferon Alfa-2b for treatment of hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/16557381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon in oncological practice: review of interferon biology, clinical applications, and toxicities

1 reference

https://pubmed.ncbi.nlm.nih.gov/16557381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention and surveillance of hepatitis B virus-related hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/16557381

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00432-006-0091-Y

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33370654&oldid=2195294080"